PHR Rule 144 Notice: Insider sale disclosure includes 17,445 shares and recent insider transactions

Rhea-AI Filing Summary

Phreesia, Inc. Form 144 shows a proposed sale of 17,445 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $518,681.81, and an approximate sale date of 08/22/2025 on the NYSE. The filing lists the acquisition history for the shares sold, all noted as restricted stock vesting between April 2022 and April 2023, paid as compensation.

The form also discloses recent sales by insiders in the past three months, including multiple small sales by Jessica Weiss and larger sales by David Linetsky (notably 23,729 shares for $676,195.48 on 06/27/2025). The filer certifies no undisclosed material adverse information at signature.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice showing insider-originated restricted shares and recent insider sales; no forward-looking claims.

The filing documents a planned Rule 144 sale of 17,445 common shares valued at $518,681.81 to be executed via Fidelity on 08/22/2025. Acquisition dates are explicit and tied to restricted stock vesting events in 2022–2023, indicating the shares were compensation-based. The schedule of recent sales shows multiple transactions by named insiders, including a 23,729-share sale for $676,195.48 on 06/27/2025. From a market-impact perspective, the document is a disclosure of intent and past insider activity rather than an operational or financial update.

Corporate Governance Expert

TL;DR: Formal insider sale notice with clear vesting provenance; disclosures align with Rule 144 procedural requirements.

The submission provides required information: broker, share counts, aggregate market value, acquisition method (restricted stock vesting), and prior three-month insider sales with gross proceeds. The signer affirms no undisclosed material adverse information. The document focuses on compliance and transparency around insider liquidity rather than signaling corporate governance changes or events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	17445	518681.81	59504269	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/13/2022	Restricted Stock Vesting	Issuer			6999	04/13/2022	Compensation
Common	04/14/2022	Restricted Stock Vesting	Issuer			2025	04/14/2022	Compensation
Common	07/14/2022	Restricted Stock Vesting	Issuer			2026	07/14/2022	Compensation
Common	09/12/2022	Restricted Stock Vesting	Issuer			963	09/12/2022	Compensation
Common	10/14/2022	Restricted Stock Vesting	Issuer			1591	10/14/2022	Compensation
Common	04/10/2023	Restricted Stock Vesting	Issuer			2448	04/10/2023	Compensation
Common	04/14/2023	Restricted Stock Vesting	Issuer			1393	04/14/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/17/2025	42	1057.23
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/18/2025	67	1715.96
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/27/2025	23729	676195.48
David Linetsky 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	2063	55465.41
Jessica Weiss 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/18/2025	78	2274.13

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)